FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 188 filers reported holding FATE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 4.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,546,371 | -42.8% | 955,120 | -31.5% | 0.03% | -51.9% |
| Q1 2023 | $7,945,601 | +84.6% | 1,393,965 | +226.8% | 0.05% | +50.0% |
| Q4 2022 | $4,304,222 | -22.1% | 426,583 | +73.1% | 0.04% | -39.0% |
| Q3 2022 | $5,524,000 | +15.6% | 246,475 | +27.8% | 0.06% | +34.1% |
| Q2 2022 | $4,778,000 | -22.7% | 192,824 | +21.0% | 0.04% | +18.9% |
| Q1 2022 | $6,180,000 | -1.5% | 159,390 | +48.6% | 0.04% | +12.1% |
| Q4 2021 | $6,276,000 | +132.5% | 107,268 | +135.5% | 0.03% | +83.3% |
| Q3 2021 | $2,699,000 | +7.0% | 45,545 | +56.7% | 0.02% | +12.5% |
| Q2 2021 | $2,523,000 | -63.9% | 29,067 | -65.7% | 0.02% | -66.7% |
| Q1 2021 | $6,990,000 | +353.0% | 84,775 | +399.7% | 0.05% | +220.0% |
| Q4 2020 | $1,543,000 | -34.7% | 16,964 | -71.3% | 0.02% | -48.3% |
| Q3 2020 | $2,363,000 | +121.7% | 59,123 | +90.3% | 0.03% | +93.3% |
| Q2 2020 | $1,066,000 | -9.2% | 31,065 | -48.2% | 0.02% | -16.7% |
| Q4 2019 | $1,174,000 | -51.4% | 60,015 | -61.4% | 0.02% | -52.6% |
| Q3 2019 | $2,417,000 | +11.9% | 155,616 | +46.3% | 0.04% | 0.0% |
| Q2 2019 | $2,159,000 | +15.5% | 106,349 | -0.0% | 0.04% | +26.7% |
| Q1 2019 | $1,869,000 | – | 106,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |